Medicine and Dentistry
Intensive Care Unit
94%
Decompressive Craniectomy
92%
Traumatic Brain Injury
87%
Cohort Analysis
77%
Randomized Controlled Trial
70%
Systematic Review
64%
Intensive Care
62%
Meta-Analysis
59%
Injury
58%
Bariatric Surgery
53%
Heart Surgery
50%
Acute Kidney Injury
49%
Venous Thromboembolism
45%
Infection
43%
Pulmonary Embolism
41%
Dexamethasone
36%
Health Care Cost
35%
Thromboembolism
33%
Cranioplasty
33%
Bleeding
32%
Retrospective Cohort Study
32%
Postoperative Complication
32%
Observational Study
31%
Hospital Mortality
29%
Odds Ratio
29%
Contraindication
25%
Prospective Cohort Study
23%
Anticoagulation
23%
Noncardiac Surgery
23%
Placebo
22%
Inferior Vena Cava Filter
21%
Venae cavae
21%
Intermittent Pneumatic Compression
20%
Out of Hospital Cardiac Arrest
20%
Cancer Surgery
20%
Randomized Clinical Trial
20%
Case-Control Study
20%
Obesity Medicine
19%
Clinical Trial
19%
Urinary System
18%
C Reactive Protein
18%
In Vitro
17%
Biological Marker
17%
Nervous System Injury
17%
Oxygen Saturation
17%
Prevalence
17%
Diagnosis
16%
Functional Status
16%
Acute Pulmonary Embolism
16%
Surgeon
16%
Nursing and Health Professions
Intensive Care Unit
100%
Confidence Interval
60%
Intensive Care
53%
Cohort Analysis
48%
Hospital Mortality
42%
Decompressive Craniectomy
38%
Acute Kidney Failure
38%
Systematic Review
36%
Hospital Readmission
36%
Receiver Operating Characteristic
35%
Injury
33%
Meta Analysis
28%
Traumatic Brain Injury
26%
Odds Ratio
25%
Heart Surgery
23%
Critical Illness
21%
Venous Thromboembolism
21%
Comorbidity
21%
Sepsis
19%
APACHE
19%
Thromboembolism
18%
Perioperative
17%
Diagnosis
17%
Furosemide
16%
Hospital Discharge
15%
C Reactive Protein
15%
Diseases
14%
Vena Cava Filter
14%
Urine Volume
14%
Eosinopenia
13%
Tissue Oxygenation
13%
Out of Hospital Cardiac Arrest
13%
Contraindication
13%
Procedural Pain
13%
Dexamethasone
13%
Lung Embolism
13%
Body Mass
13%
Bloodstream Infection
12%
Acute Disease
11%
Filter
10%
Placebo
10%
Pain Intensity
10%
Prospective Cohort Study
9%
International Normalized Ratio
9%
near Infrared Spectroscopy
9%
Bleeding
9%
Anticoagulation
8%
Biological Marker
8%
Activated Partial Thromboplastin Time
8%
Pilot Study
8%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
52%
Acute Kidney Failure
48%
Venous Thromboembolism
45%
Cohort Study
40%
Dexamethasone
36%
Biological Marker
33%
Infection
31%
Injury
29%
Placebo
29%
Comorbidity
27%
Traumatic Brain Injury
27%
Acute Disease
23%
Lung Embolism
23%
Randomized Clinical Trial
20%
Clinical Trial
19%
Low Molecular Weight Heparin
17%
Bleeding
17%
Hypertensive Factor
16%
Hospital Mortality
15%
Sepsis
14%
Critical Illness
14%
Postoperative Complication
14%
Melatonin
13%
Case-Control Study
13%
Delirium
13%
Functional Independence Measure
13%
Thromboembolism
13%
Diseases
13%
C Reactive Protein
12%
Inflammation
12%
Creatinine
11%
Head Injury
10%
Surgical Infection
10%
Furosemide
9%
Postoperative Nausea and Vomiting
9%
Observational Study
9%
Replacement Therapy
9%
Long Term Survival
9%
Frailty
9%
Prospective Cohort Study
8%
Warfarin
8%
Contrast Induced Nephropathy
8%
Bloodstream Infection
8%
Iron
8%
Hypotension
8%
Thromboplastin
7%
Glucocorticoid
7%
Blood Clotting Disorder
7%
Ergothioneine
7%
Amino Acid
7%